SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Lee Warzala who wrote (787)6/2/1997 8:08:00 AM
From: John Metcalf   of 6136
 
The article was about government initiatives to allow Medicaid to pay for protease inhibitors and rti's earlier in the course of an AIDS infection. There is a sizable body of opinion that the new combination drug regimens will save total hospital/medical costs if used early.

Unfortunately, current Medicaid regulations require a person to be disabled (unable to engage in substantial gainful activity) before Medicaid will pay for treatment. Thus, the Feds are talking about grating waivers to States for demonstration projects in order to provide combo therapy before the disease has done its damage. If drugs are started earlier, careers will be prolonged, more taxes will be collected, and total treatment costs will be reduced.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News